# The Use of ADV6209 for Premedication in Pediatric Anesthesia

> **NCT03931057** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 80 (actual)

## Conditions studied

- Preanesthetic Medication

## Interventions

- **DRUG:** ADV6209 (=gamma-cyclodextrin-Midazolam)
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03931057
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-16
- **Primary completion:** 2021-09-17
- **Final completion:** 2021-09-17
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03931057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03931057, "The Use of ADV6209 for Premedication in Pediatric Anesthesia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03931057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*